Abstract:RNAs regulate multiple biological processes including RNA transcription, splicing, stability, and translation. They play significant roles in cell biology (Connelly et al. (2016); Licatalosi and Darnell (2010); Mukherjee et al. (2022); Chen et al. (2018b)). The Encyclopedia of DNA elements project reported that only 1.5% of human genome is translated into proteins, while approximately 70%–90% is transcribed to RNAs (Falese et al. (2021)). RNAs greatly expand the range of targets from proteins to RNAs by retargeting mutated targets (Yu et al. (2019); Chen et al. (2020); Li et al. (2022); Yang et al. (2022)). Particularly, noncoding RNAs have dense linkages with human diseases including cancers. Now, RNAs have been diagnostic or prognostic markers of complex diseases (Hui et al. (2011); Xu et al. (2022); Peng et al. (2022a); Shen et al. (2022); Zhang T. et al. (2022); Chai et al. (2022)). In this topic, we aim to analyze diverse RNA data to provide clues for the diagnosis and therapy of various diseases (Dal Molin et al. (2022); Wang S. et al. (2022); Li J. et al. (2019); Liu et al. (2020)). Long noncoding RNAs (lncRNAs) regulate many significant biological processes (such as immune response and embryonic stem cell pluripotency) by linking to RNA-binding proteins (Wapinski and Chang (2011); Chen and Huang (2017); Ping et al. (2018); Wang et al. (2020)), Wang et al. (2021W.); Peng et al. (2020)). They have been important biomarkers for cancers (Wu et al. (2022a); Banerjee et al. (2020); Zhang S. et al. (2021); Zhou G. et al. (2021); Peng et al. (2022a); Liang et al. (2022b); Peng et al. (2021); Zhou L. et al. (2021)). For example, lncRNAs AFAP1-AS1, CCAT1, CYTOR, GAS5, HOTAIR, and PVT1 are molecular regulators of lung caner (Aftabi et al. (2021)). KCNQ1OT1may be a prognostic biomarker in colorectal cancer (Lin et al. (2021)). lncRNAs are also oncogenes (such as MKLN1-AS, GHET1, LASP1-AS, MALAT1, HULC, HOTAIR, and PAPAS) and tumor suppressors (such as CASC2, DGCR5, MEG3, GAS5, and NRON) in hepatocellular carcinoma (Guo et al. (2021)). Many machine learning methods have been proposed to OPEN ACCESS

Editorial: Non-coding RNAs and human diseases volume 2 -long non-coding RNAs and pathogenesis of human disease

Long non‑coding RNAs: novel links in respiratory diseases (review).

Mysterious long noncoding RNAs and their relationships to human disease

Long Non-Coding RNAs: a New Frontier in the Study of Human Diseases.

Non-coding RNAs and Diseases

Editorial: Machine Learning-Based Methods for RNA Data Analysis—volume II

Long Noncoding RNAs: Insights from Biological Features and Functions to Diseases.

Long Non-Coding RNAs and Complex Human Diseases

LncRNA: a New Perspective on the Study of Neurological Diseases

Long Noncoding RNA: Genomics and Relevance to Physiology.

Bioinformatics Analysis of Long Non-coding RNA and Related Diseases: An Overview

Characters, functions and clinical perspectives of long non-coding RNAs

Long non-coding RNAs: From disease code to drug role

Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets

The relationship between long non-coding RNA and cardiovascular development and diseases

Non-coding RNAs in disease: from mechanisms to therapeutics

Некодирующие РНК и болезни

Progress on Relationship between Non-coding RNA and Diseases

Long Non-Coding RNA: Research Progress

Progress in Non-Coding RNA Research

Research Progress of Long Noncoding RNAs